Trials
Search / Trial NCT06428669

Effect of Nitropaste in Chest Masculinizing Surgery

Launched by UNIVERSITY OF VIRGINIA · May 20, 2024

Apply for Trial

Trial Information

Current as of March 14, 2025

Recruiting

Keywords

Gender Affirming Surgery Chest Masculinizing Surgery Nitropaste Wound Healing

ClinConnect Summary

This clinical trial is studying the use of a medication called Nitropaste during chest masculinizing surgery, which is a procedure some people undergo to create a more masculine chest appearance. Nitropaste, which contains a small amount of nitroglycerin, is typically used to help with heart conditions but has shown promise in improving healing after certain types of surgeries. The goal of this study is to see if applying Nitropaste can help reduce complications, such as wound issues, after surgery.

To participate in this trial, you must be an adult (18 years or older) who is planning to have chest masculinizing surgery that includes a double incision and free nipple grafting. Unfortunately, younger individuals, those not having the specific type of surgery mentioned, or people with certain health conditions will not be able to join. If you do take part in the study, you’ll be closely monitored during and after the surgery to see how well the treatment works and how well you heal. This trial is currently looking for participants, and it could help improve outcomes for others in the future.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • • Any adult (18 or older) patients of any gender identity who are undergoing chest masculinizing surgery with double incision and free nipple grafting.
  • Exclusion Criteria:
  • • Minor patients (younger than 18)
  • • Anyone who's not getting free nipple grafting
  • • Anyone who's not utilizing double incision pattern
  • • Prisoners, anyone who is allergic to nitropaste
  • • Anyone who is taking phosphodiesterase inhibitor (ex)Sildenafil, tadalafil, vardenafil)
  • • Anyone who's taking soluble guanylate cyclase stimulator riociguatdz

Trial Officials

John T Stranix, MD

Principal Investigator

UVA

About University Of Virginia

The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.

Locations

Charlottesville, Virginia, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0